Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
Am J Hematol
; 98(5): 730-738, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-36869876
Full text:
1
Database:
MEDLINE
Main subject:
Leukemia, Plasma Cell
/
Hematopoietic Stem Cell Transplantation
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Aged
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Am J Hematol
Year:
2023
Type:
Article
Affiliation country:
Greece